HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thierry Connerotte Selected Research

HLA-A1 Antigen (HLA A1 Antigen)

5/2008Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities.
10/2004Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.
11/2003Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thierry Connerotte Research Topics

Disease

7Neoplasms (Cancer)
05/2008 - 10/2002
5Melanoma (Melanoma, Malignant)
05/2008 - 10/2002
1Body Weight (Weight, Body)
05/2017
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2017
1Disease Progression
05/2017
1Pneumonia (Pneumonitis)
11/2008

Drug/Important Bio-Agent (IBA)

5AntigensIBA
05/2008 - 10/2002
4Peptides (Polypeptides)IBA
05/2008 - 11/2002
3HLA-A1 Antigen (HLA A1 Antigen)IBA
05/2008 - 11/2003
2VaccinesIBA
06/2005 - 10/2004
1Imatinib Mesylate (Gleevec)FDA Link
05/2017
1Tyrosine Kinase InhibitorsIBA
05/2017
1Bleomycin (Blenoxane)FDA LinkGeneric
11/2008
1Deoxyglucose (2 Deoxy D glucose)IBA
11/2008
1AutoantigensIBA
05/2003
1MART-1 AntigenIBA
11/2002
1HLA-A2 Antigen (HLA A2 Antigen)IBA
11/2002
1Proteins (Proteins, Gene)FDA Link
11/2002

Therapy/Procedure

1Immunotherapy
06/2005